Former MLB player Dave Winfield shares lessons from baseball, philanthropy
In this episode of Speaking of Urology®, former Major League Baseball (MLB) player, Dave Winfield, shares lessons he’s learned throughout his professional baseball career and his work in philanthropy....
15 Marras 202434min
Key updates from the AUA/ASRM male infertility guideline amendment
In this episode of Speaking of Urology®, Juan J. Andino, MD, MBA, speaks with Robert E. Brannigan, MD on the recent amendment to the American Urological Association (AUA) guideline on male infertility...
23 Syys 202430min
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen. Winter is a urologist and sexual medicine expert in Los Angeles, California.
24 Heinä 202426min
Health policy in urology: 2024 AUA Advocacy Summit recap
In this episode of Speaking of Urology®, Eugene Rhee, MD, MBA, and Logan Galansky, MD, discuss key topics in health policy for urology and recap the American Urological Association’s (AUA) recent Annu...
21 Maalis 202434min
Dr. Murphy on increasing diversity in cancer clinical trials
In this interview, Adam B. Murphy, MD, MBA, MSCI, discusses the need to increase diversity in clinical trials, specifically focusing on studies in prostate cancer.
29 Helmi 202413min
Speaking of Urology: Liquid biopsy in prostate cancer
In this episode of Speaking of Urology®, David M. Albala, MD, and Sanoj Punnen, MD, discuss precision medicine and the use of biomarker tests in prostate cancer screening and detection. Albala is the ...
14 Joulu 202330min
How APPs can bridge the gap in urologist shortages
In this interview, Janelle Bunce, PA-C highlights the role that advanced practice providers (APPs) can play in filling the gaps created by the growing workforce shortages in urology. Bunce is a physic...
28 Elo 202311min
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
In this episode, David M. Schuster, MD, FACR, highlights the recent FDA approval of flotufolastat F 18 (POSLUMA), a PSMA-PET imaging agent in prostate cancer. Schuster is a professor of radiology and ...
22 Kesä 202314min
